# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-025389
Filing Date
2021-05-10
Accepted
2021-05-10 16:55:41
Documents
91
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0321_abvcbio.htm | 10-Q | 739476
2 | CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FILED ON FEBRUARY 17, 2021 | f10q0321ex3-6_abvcbio.htm | EX-3.6 | 1258
3 | CERTIFICATION | f10q0321ex31-1_abvcbio.htm | EX-31.1 | 9366
4 | CERTIFICATION | f10q0321ex31-2_abvcbio.htm | EX-31.2 | 9432
5 | CERTIFICATION | f10q0321ex32-1_abvcbio.htm | EX-32.1 | 4523
6 | CERTIFICATION | f10q0321ex32-2_abvcbio.htm | EX-32.2 | 4261
7 | GRAPHIC | ex10a_001.jpg | GRAPHIC | 390126
8 | GRAPHIC | ex10a_002.jpg | GRAPHIC | 263044
| Complete submission text file | 0001213900-21-025389.txt |  | 6530465

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | abvcd-20210331.xml | EX-101.INS | 871986
10 | XBRL SCHEMA FILE | abvcd-20210331.xsd | EX-101.SCH | 88169
11 | XBRL CALCULATION FILE | abvcd-20210331_cal.xml | EX-101.CAL | 39880
12 | XBRL DEFINITION FILE | abvcd-20210331_def.xml | EX-101.DEF | 337835
13 | XBRL LABEL FILE | abvcd-20210331_lab.xml | EX-101.LAB | 619642
14 | XBRL PRESENTATION FILE | abvcd-20210331_pre.xml | EX-101.PRE | 351526

Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 21908084
SIC: 2834 Pharmaceutical Preparations